Amp Ltd. Aktie
Finanztrends
Deine Einschätzung
Was spricht für und gegen Amp Ltd. in den nächsten Jahren?
Pro
?
W******* i* V********
?
L*********** I********** f** d** n******* J****
?
A****************
Kontra
?
U****************
?
M****
?
M************
Sag uns deine Meinung, um die 'Wisdom of the Crowds' zu nutzen
Rendite von Amp Ltd. im Vergleich
| Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
|---|---|---|---|---|---|---|---|
| Amp Ltd. | 3,15 % | 0,77 % | 27,18 % | 48,02 % | 27,18 % | 103,10 % | 101,54 % |
| National Australia Bank | 4,44 % | 2,57 % | 11,10 % | 21,16 % | 9,37 % | 56,56 % | 58,97 % |
| Commonwealth Bank Australia | 1,49 % | 1,58 % | 9,53 % | 14,50 % | 21,81 % | 84,11 % | 75,25 % |
| Macquarie Group Ltd | 2,93 % | 2,02 % | 3,80 % | 34,53 % | 39,17 % | 55,31 % | 65,14 % |
Kommentare
News
Ardagh Metal Packaging Q2 Earnings Call Highlights
Key Points
- Interested in Ardagh Metal Packaging S.A.? Here are five stocks we like better.
- Ardagh Metal Packaging raised full-year 2026 adjusted EBITDA guidance to $775 million-$790 million
Amphastar Pharmaceuticals Pivots to Proprietary Drugs, Biosimilars for Growth
Key Points
- Interested in Amphastar Pharmaceuticals, Inc.? Here are five stocks we like better.
- Amphastar is shifting its strategy from complex generics toward proprietary drugs and
Pennon Group H2 Earnings Call Highlights
Key Points
- Interested in Pennon Group Plc? Here are five stocks we like better.
- Pennon returned to profitability in 2025/2026, with EBITDA up 55% and underlying operating profit more than